Search
Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
Researchers identify a compound that appears to eliminate tumor cells in a dish and in mice.
The findings will lead to more accurate diagnoses and, potentially, to better treatments.
Learn about how nutrition experts are helping people with cancer maintain a healthy diet both during and after treatment.
An international team of researchers led by Howard Scher, MD, Co-Chair of the Center for Mechanism Based Therapy and Head of the Biomarker Development Initiative at Memorial Sloan Kettering Cancer Center (MSK), has validated a biomarker that can predict whether people with metastatic castration-resistant prostate cancer (mCRPC) may live longer if they are treated with a taxane-based chemotherapy instead of a second targeted androgen receptor–signaling inhibitor (ARSi).
Read about a first-of-its kind PhD program that enables aspiring scientists to tackle tough cancer problems.
Learn how one man's determination to be a doctor took him on an incredible journey from working at a car wash in the Bronx to becoming a physician at Memorial Sloan Kettering Cancer Center, with the help of mentors and a world-class work ethic.
Gerstner Sloan Kettering student Jessica Rios-Esteves has been awarded the Chairman’s Prize for her first-author paper published in Cell Reports in 2013.
Learn more about how MSK helps international patients like Annabel Gutherz, a 25-year-old singer from Montreal who sought MSK's expertise in head and neck cancer and found comfort and support far from home.
Memorial Sloan Kettering researchers have discovered that the AR and PI3K disease pathways regulate each other through reciprocal negative feedback.